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Abstract
Background Peripheral arterial disease (PAD) is a common condition that causes significant morbidity and reduced life 
expectancy, and can have a serious economic impact. It is often underdiagnosed in primary care, partially due to the fact 
that the current National Institute for Health Care and Excellence-recommended ankle-brachial pressure index (ABPI) test 
for PAD in primary care is time-consuming and is technically challenging to perform. The availability of a simple, reliable 
diagnostic test has the potential to facilitate early PAD identification and treatment.
Objective The aim of this study was to evaluate the preferences of primary care practitioners relating to the key character-
istics for a new medical device for PAD detection.
Participants A sample of 116 UK primary care setting clinicians involved in the diagnosis and/or management of PAD, 
comprising of doctors (n = 95), nurses (n = 17), health care assistants (n = 1) and other unspecified clinicians (n = 3).
Outcomes Relative weights derived from a discrete choice experiment (DCE), by primary care practitioners regarding six key 
characteristics of the new device: device display, data integration, training, power supply, portability of the device, and cost.
Results Five characteristics were important for preferences. Practitioners favoured manual, as opposed to automated, inte-
gration of test results into patient records. Practitioners strongly preferred disposable batteries as the power supply for the 
device compared with other alternatives.
Conclusions This novel study has successfully utilised a DCE to elicit primary care practitioner’s preferences for the develop-
ment of the new device. The preferences can help inform device design and therefore facilitate/help to maximise its uptake 
and buy-in from the outset.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s4166 9-019-0135-2) contains 
supplementary material, which is available to authorized users.
 * Luke Vale 
 luke.vale@newcastle.ac.uk
1 Institute of Health & Society, Newcastle University, 
Newcastle upon Tyne, UK
Key Points for Decision Makers 
This study has shown that a discrete-choice experiment 
(DCE) can be successfully used to help understand the 
important characteristics to users of a new diagnostic device.
DCEs can be used in the primary care setting to aid decision 
making relating to the implementation of medical technology.
Decision makers can make informed commissioning 
decisions using information from DCEs, relating to the 
use of existing and new medical devices.
2 Institute of Cellular Medicine, Newcastle University, 
Newcastle upon Tyne, UK
1 Introduction
Peripheral arterial disease (PAD) can be asymptomatic, 
can cause leg pain on walking, or may progress to cause 
ulcers or gangrene, leading to limb amputation [1, 2]. 
Symptomatic PAD affects approximately 5% of people 
aged 55 years and over [3], and 100,000 people are diag-
nosed with PAD each year in the UK. These people are 
approximately sixfold more likely to suffer a heart attack 
or stroke than those without PAD as PAD is usually asso-
ciated with atherosclerosis. Detecting PAD early allows 
cardiovascular risk factors to be controlled early, and 
allows the implementation of lower cost therapies that 
prevent costly and harmful longer-term adverse events 
from occurring. A new test for early PAD detection, and 
a formal evaluation would be of value, but integral to that 
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evaluation is the need to understand whether the test would 
be adopted in practice. This issue can be explored using 
economic approaches to quantify the strength of prefer-
ence for the use of a test by those who used it in practice.
The National Institute for Health and Care Excellence 
(NICE) guidance for PAD testing [4] in primary care is to 
use the ankle-brachial pressure index, however it is time-
consuming and technically challenging to perform. There 
are currently no easy-to-use PAD detection devices on the 
market that require minimal training and that have been 
informed by the preferences of UK-based primary care 
clinicians. Besides ABPI limb pressure measurements, 
there are other approaches that can be used, including 
the potentially very low-cost vascular optical technique 
known as photoplethysmography (PPG) [5]. PPG meas-
ures the pulse at peripheral sites such as the finger or toe, 
with the pulse having distinct characteristics when there is 
PAD present in the limb being studied. A novel rapid PAD 
detector device based on multi-site PPG (base technology 
called MPPG) [5, 6] is being developed for primary care 
use. This device aims to be comfortable for patients, non-
invasive, low-cost, safe, and easy and quick to use by a 
range of clinicians.
In order to incorporate preferences of primary care 
practitioners and maximise the suitability of a new PAD 
detection device for general practitioners (GPs) and prac-
tice nurses, a discrete choice experiment (DCE) was con-
ducted among clinical practitioners. The DCE facilitated 
the identification and exploration of the extent to which a 
practitioner values different aspects of the MPPG-based 
device. An investigation of the value attached to different 
aspects of the proposed MPPG device was undertaken.
In the DCE reported in this paper, the diagnostic 
technology is described in terms of its characteristics or 
attributes. The extent to which a practitioner values the 
technology would depend on the level of those attributes 
(see Table 1). By presenting questions that compare two 
profiles that differ by the level of the attributes presented, 
it is possible to estimate the uptake of a technology that 
might be configured in different ways [7].
1.1  Objective
The overall aim of this study was to determine the strength 
of practitioners’ preferences, using a DCE, for different char-
acteristics describing a new diagnostic device for the detec-
tion of PAD. In order to address the study aim, the DCE 
answered the following key questions.
• What key characteristics should be considered in the 
development of a novel rapid PAD detection device 
(based on MPPG), from the perspective of primary care 
practitioners?
• What are the relative preferences for different levels of 
these attributes among practitioners?
• In what ways can the results from the DCE be used to 
inform future product investment and development deci-
sions?
2  Methods
DCEs are an economic technique used to explore prefer-
ences for different types of service, policy or intervention 
[8], and have been used extensively to explore patient, 
provider and policy-maker preferences for different char-
acteristics of goods and services [9]. They have been used 
extensively in health care, and recent reviews have identified 
several hundred different DCEs that have been reported in 
recent years [10, 11]. The design of the DCE in the current 
study followed well-documented guidelines for best practice 
[7, 12, 13]. The methods that were employed can be broken 
down into four key steps: Step 1: Identification of attributes 
and levels; Step 2: Experimental design; Step 3: Data collec-
tion, and Step 4: Data analysis and interpretation.
2.1  Step 1: Identification of Attributes and Levels
Two main sources were used to inform the list of attributes 
and levels that were included in the DCE: an expert panel 
(comprising the clinical specialists and device designers 
in the project team), and preceding qualitative studies that 
were undertaken in the wider device development project. 
This qualitative study comprised five focus groups explor-
ing views on the device that fed into the identification and 
wording for the attributes contained in the DCE study. The 
interviews were conducted between December 2014 and 
February 2016: three were in general practices, and two 
were with Tissue Viability Nurses. The breakdown of health 
care practitioners was 14 GPs and 20 nurses (a mix of Dis-
trict Nurses, Tissue Viability Nurses and Practice Nurses). 
Specifically, details on the (1) sensitivity and specificity 
of the test, and (2) device acceptability, ease of interpreta-
tion, and confidence in findings, were provided from this 
qualitative work. All of the information elicited from the 
consultations were consolidated, facilitating the creation of 
key attributes and associated levels that may influence the 
uptake of the new PAD detection device, from the perspec-
tive of practitioners. In addition to this, the clinicians and 
device developers who formed part of the study team also 
had input in the final refinement of attributes and levels, 
prior to piloting the DCE survey. Finally, qualitative work, 
in terms of think-aloud [14] interviews with clinicians, were 
conducted as part of the health economics DCE to finalise 
attributes and levels for inclusion (further details are pro-
vided in the Think-Aloud Pre-Testing and Data Collection 
573A DCE to Estimate Preferences for a Novel Non-invasive Device for Diagnosis of PAD
section below). Table 1 shows the finalised list of attributes 
and levels that was included in the DCE. An experimental 
design, generated for the DCE, is described in the next step.
2.2  Step 2: Experimental Design
All possible combinations of attributes and levels described 
in Table 1 generated a large number of profiles, i.e. 1536 
 (22 × 3 × 42 × 8). Each profile is made up of one level 
for each attribute. A set of choice scenarios can be defined 
where each profile is compared with another profile. The 
total number of scenarios generated is therefore too large 
to be considered by individuals. Consequently, an efficient 
design was selected that allowed for all main effects to be 
estimated [7, 10]. The design for the DCE was generated 
using the Ngene design software [15]. The best design gen-
erated by Ngene was chosen with the aim of minimising the 
standard errors [16] (the reliability of the model parameters 
to be estimated can be quantified in terms of the asymp-
totic standard errors and covariances; thus improvements in 
reliability suggested a reduction in the asymptotic standard 
errors) [17]. In order to reduce respondent fatigue, we chose 
an efficient design that consisted of 20 choices. This was 
felt to be too many for respondents, therefore two blocks of 
choice scenarios were generated, each made up of 10 sce-
narios, and each respondent was randomly assigned to one 
block of choice scenarios.
An example pairwise choice set is shown in Fig. 1. Prac-
titioners were asked to choose their preferred scenario from 
each pairwise choice set. The full online questionnaire incor-
porated questions on (1) background data (including age, 
sex, profession, and experience with using PAD detection 
devices); (2) introductory text explaining the DCE task, and 
an example DCE question (this was an independent question 
that was not generated from the experimental design; the 
same question was shown to all survey respondents) [see 
Table 1  Attributes and levels included in the discrete choice experiment
Attribute Levels Level code Regression 
variable 
name
Device display (pic-
torial attribute)*
Two traffic light and test confidence 0 Traffic2
Three traffic light and probability of having PAD 1a NA
Scale and score and test confidence 2 Scale
Data integration Manual (e.g. input results into a patient’s record by hand) 0 Man
Automated (e.g. direct upload from the device via USB or wireless connection) 1a NA
Training Paper manual and formal face-to-face training course 0 FF
Paper manual and formal face-to-face training course, and electronic user guide integrated into 
the device
1 FF_ElecU
Paper manual and training video or interactive online training (e.g. webinar/webex) 2 Vid_ElecU
Paper manual and training video or interactive online training (e.g. webinar/webex) and elec-
tronic user guide
3a NA
Cost of device £500 NA Cost
£750
£1000
£1250
£1500
£1750
£2000
£2500
Power supply Disposable batteries with an indicator to show low battery life of the device 0 Disp_Batt
Rechargeable batteries with USB charger with an indicator to show low battery life of the 
device
1 Rech_Batt
Inductive (wireless) charging of the pods attached to the finger and toe probes with an indicator 
to show low battery life of the device
2a NA
Wired charging of the pods attached to the finger and toe probes with an indicator to show low 
battery life of the device
3 Wired
Portability of device The device can be moved from room to room (on a trolley and/or carried) 0 Room
The device is small enough to put in a portable bag and taken to a patient’s home for use by the 
health care professional
1a NA
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NA not applicable, PAD peripheral arterial disease
a Base level for each attribute
*Pictures used for the device display aribute: 
Device display aribute levels
Two Traffic light & Test confidence Three Traffic light & Probability of having PAD Scale & Score & Test confidence
Fixed characteriscs of the device – described within the introductory text to the DCE survey
• The device is intended for primary care health praconers and not for self-administraon, by paents themselves
• Diagnosc accuracy –The device is as accurate as other PAD detecon devices available on the market
• Time to result – Assume the current standard 10 minutes resng (acclimazaon) me as recommended by NICE (though this could be 
accommodated outside of a standard 10 minute GP appointment)
• Life span of device - A shelf life of at least 5 years 
• Paent’s measurement posion – measurements will need to be collected in the standard vascular posture and be taken lying down
• Infecon control – The device will have disposable covers for the finger and toe probes and that the display unit meets infecon control 
requirements for medical devices
• The device is validated specifically for the use of lower limb PAD detecon.
Table 1  (continued)
the electronic supplementary material, which illustrates 
the DCE section of the online survey]; and (3) the main 
DCE survey—the 10 DCE choice questions presented to 
respondents, following the DCE section of the survey, a 
ranking exercise where respondents were asked to rank the 
six attributes making up the choice sets; and (4) additional 
questions used to explain how individuals had answered the 
DCE questions. In the final section, additional comments 
on the diagnosis of PAD were included. A final question on 
whether any key attributes were missing from the DCE was 
also included.
2.3  Step 3: Data Collection
2.3.1  Recruitment of Participants and Consent
The DCE was converted into an online survey by a market 
research company (Research Now), who conducted the DCE 
to standards described in the Market Research Society’s 
Code of Conduct [18]. An incentive in the form of a prize 
draw (an  iPad™) was offered for full completion of the sur-
vey. All participants were provided with written information 
on the study before taking part, and indicated their consent 
before data collection took place.
Clinicians involved in the care pathway in the diagnosis of 
PAD were recruited via a number of avenues in order to achieve 
the required sample required. The National Health Service 
(NHS) North of England Commissioning Support Unit, and 
North East and North Cumbria Clinical Research Network, 
helped with the recruitment of clinicians in the following ways:
• the survey link was sent to GP practices for accessing 
GPs, practice nurses and other non-medically qualified 
clinicians’
• district and community nurses who are employed by 
acute trusts could be contacted using existing links to 
cascade the survey widely.
In addition to the above, clinical conferences, such as 
the ‘Issues and Answers in Cardiovascular Disease’ pri-
mary care conference that took place in Nottingham, UK, 
4–5 November 2016, were targeted for recruitment. This 
conference was specifically chosen because the conference 
delegates comprised GPs and nurses working in the primary 
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care setting. The link for the survey was made available on 
the conference website on 3rd November 2016 and was live 
for a full week following the conference so practitioners 
could go back and take the survey at their convenience.
2.3.2  Sample Size
Optimal sample size requirements for DCEs depend on 
knowledge of the true choice probabilities, which are not 
known prior to undertaking the research [19]. For this rea-
son, DCE sample size estimates are generally based on 
previous research, rules-of-thumb and budget constraints. 
Previous DCE studies have shown that robust choice models 
can be estimated in samples as low as 50 respondents [19, 
20]. Given the number of attributes included in the DCE, it 
was estimated that a minimum sample size of 100 (i.e. 50 per 
block) would provide sufficient statistical power.
2.3.3  Think‑Aloud Pre‑testing and Data Collection
The DCE was pre-tested and piloted prior to the main survey 
data collection. A convenience sample of four clinicians, com-
prising one GP and three nurses who were independent of the 
research team, reviewed the survey. A think-aloud approach 
was used with clinicians to identify any necessary adaptation 
of the pairwise scenarios and overall survey. An iterative pro-
cess was taken to incorporate feedback from each think-aloud 
participant.
Fig. 1  Screenshot of an example discrete-choice experiment scenario. PAD peripheral arterial disease
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The first participant (nurse) suggested making some 
changes to the introduction section (e.g. making it shorter). 
This participant confirmed that they understood each of the 
attributes and associated levels and did not suggest any fur-
ther changes. The second participant (GP) suggesting mak-
ing the cost for the introductory test DCE question the same 
in the two alternatives to encourage participants to fully take 
in the other attributes in the first instance. They also sug-
gested that the original maximum value be reduced (origi-
nally set at £6000 with a view to getting feedback from prac-
titioners). The third participant (nurse) suggested that the 
maximum value for the cost of the device should be £2500 
and that more cost levels should be added at the lower cost 
end of the scale. The fourth participant (nurse) gave posi-
tive feedback regarding the final levels of the cost attribute, 
but did not suggest making any changes. The feedback was 
positive that the DCE task was well understood.
2.4  Analysis of the Discrete‑Choice Experiment 
(DCE) Data
A conditional logit regression model (i.e. multinomial 
model) was used to investigate the main effect parameters, 
applied on the full respondent sample. The utility function 
( 휇 ) modelled is based on Eq. (1). The model was imple-
mented in STATA software (version 14.0; StataCorp LLP, 
College Station, TX, USA) [21]. The model used assumed 
that all attributes have an independent influence on prac-
titioners’ preference(s). The functional form incorporated 
dummy attribute-level coefficients (as per Table 1) so that:1
where 휇 = the indirect utility function of individual q for 
alternative j, 훼 = the alternative-specific constant term (for 
choosing scenario A in the current context), 휆′퐗qj = the vec-
tor of preferences for the attributes and associated levels 
included in the DCE survey, for each of the choice tasks 
included in the DCE survey (t = 1,…, T), and 휀qj  = the ran-
dom element that is added to reflect the unobservable factors 
affecting the estimation of the indirect utility function.
A conditional logit model was used to establish whether 
the six attributes presented in the choice scenarios were sta-
tistically significant predictors of participants’ preferences. 
The model was run on the full study sample and also on the 
GP-only subsample in order to investigate potential differ-
ences in preferences between GPs and non-GPs. Dummy 
coding was used for all attributes, with the exception of the 
(1)휇qj =∝ +휆�퐗qj + 휀qj,
cost of device, which was assumed to be a continuous vari-
able. Marginal rates of substitution (MRS) [13] were used to 
estimate trade-offs between attributes and levels. The MRS 
allows us to look at trade-offs responders would be willing to 
make between each attribute when compared against a com-
mon numeric value scale. In the current study, this would be 
in terms of the cost of device attribute as the denominator 
to compare all other attributes against. Attribute levels with 
negative preferences indicate that respondents would prefer 
not to move from the reference level, while attribute levels 
with positive preferences indicate that respondents would 
prefer to move to that level from the reference level.
3  Results
Between July and December 2016, 140 individuals con-
sented to participate in the study, of whom 116 (83%) 
completed all 10 of the DCE scenarios; the data from these 
individuals were used in the DCE analysis. Of the 24 indi-
viduals who initially consented to take part in the study, 
two partially completed the DCE (one individual dropped 
out after completing the example DCE question and the first 
DCE scenario, while the other dropped out after complet-
ing the third DCE scenario) and the remaining 22 individu-
als dropped out of the survey after partially completing the 
descriptive characteristics questions (e.g. sex, clinical dis-
cipline). Participant characteristics are described in Table 2. 
The majority of the sample comprised doctors (n = 95), fol-
lowed by nurses (n = 17). One Health Care Assistant com-
pleted the survey and three individuals who did not specify 
their clinical discipline also completed the survey.
Table 3 shows the results of the conditional logit model 
for the full study sample, as well as for the GP-only sub-
sample. Here, positive coefficients represent a positive 
preference (utility) associated with a particular level of an 
attribute compared with the reference level, whereas nega-
tive coefficients represent a negative preference (disutility). 
Statistically significant differences are marked. Scenario A 
(the hypothetical scenario presented on the left-hand side of 
the screen) was the most frequently chosen option, making 
up 72% of responses.
For the full participant sample, clinicians had overall 
strong (statistically significant) preferences for five of the 
six attributes considered in the DCE. Estimates for the 
display attribute indicate a preference for the ‘two traf-
fic lights’ results display (as opposed to the ‘three traffic 
light’ result display, which was used for the reference cat-
egory). There is a slight overlap between the confidence 
intervals for the scale and two traffic light display level 
options for the display attribute, indicating the possibility 
that the latter might be preferred to the former. There was 
1 Equation  (1) assumes that there are no interactions between the 
attributes contained in the DCE Full clogit model estimated: ASC_A 
+ Traffic2 + Scale + Man + FF + FF_ElecU + Vid_ElecU + Disp_
Batt + Rech_Batt + Wired + Room + Cost (see Table 1 for full vari-
able names).
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a preference for manual input of the test results into patient 
records. Practitioners had a strong preference for training 
to be delivered via a paper manual and training video or 
interactive online training. In terms of power supply (for 
charging the device), there was a strong preference for the 
use of disposable batteries with an indicator light to show 
the low battery life of the device. Practitioners did not 
show any preference between the two levels for portability 
of the device. For the GP-only subsample, the main differ-
ence, compared with the full study sample, was that none 
of the levels for the device display attribute was statisti-
cally significant. In addition to this, only the disposable 
battery level for the power supply attribute was statistically 
significant. The magnitudes and signs of the other statisti-
cally significant coefficients where similar to those of the 
full study sample.
The attribute for the cost of the device was treated as a 
continuous variable. We usually observe negative utility 
associated with higher costs (generally individuals would 
typically prefer to pay a lower amount for a given good or 
service), and therefore expect the coefficient to be nega-
tive; however, this was not observed in this context. The 
coefficient on the cost attribute was positive and statisti-
cally significant, suggesting that there is a willingness to 
pay more for the new device.
Table 2  Characteristics of the DCE sample
NA not applicable, DCE discrete-choice experiment, PAD peripheral arterial disease, SD standard deviation, GP general practitioner
Variable Category Individuals completing all 10 
DCE scenarios [n = 116]
Mean (SD) n (%)
Questionnaire version 1 54 (46)
2 62 (53)
Age, years 44 (8) 116 (100)
Male 59 (51)
Length of time as a fully qualified nurse or doctor (years) Doctor 20 (9) Doctors n = 94 (82)
Nurse 26 (9) 12 (10)
Health care assistant 8 (NA) 1 (1)
Other (details not provided) NA 4 (3)
Other (tissue viability nurse/specialist nurse) NA 5 (4)
Length of time working in primary care (years) 14.27 14.3 (8.64) 116 (100)
Clinical discipline GP fully qualified (salaried or partner or locum) 89 (76.7)
GP in training 1 (< 1)
GP registrar 4 (3.4)
Practice nurse 8 (6.9)
Nurse practitioner 3 (2.6)
Community matron 1 (< 1)
Health care assistant 1 (< 1)
Other (please give details) 9 (8)
Location South East 18 (15.5)
London 1 (< 1)
North West 1(< 1)
West Midlands 7 (6)
South West 52 (45)
Yorkshire and the Humber 7 (6)
North East 30 (26)
Ethnicity White 102 (88)
Asian 8 (7)
Black 4 (3)
Other 1 (< 1)
Prefer not to say 1 (< 1)
Currently involved in the diagnosis and detection of PAD Yes 116 (100)
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MRS were calculated for the statistically significant 
levels for each of the attributes, to obtain willingness-to-
pay estimates. Willingness-to-pay estimates were calcu-
lated, however given that the cost of device attribute was 
problematic to estimate, MRS estimates would have also 
limited reliability. Nevertheless, from the ranking of the 
attributes (Table 4), conducted after completing the DCE 
section of the survey, it can be seen that the cost attribute 
was deemed an important consideration for a new medical 
device. For the majority of the study sample (63%), the cost 
of the device was ranked either first or second out of the 
six attributes presented. The display and portability of the 
device were also in the top-ranking attributes, by respond-
ents (ranked number 1 by at least 41% of respondents). The 
training and power supply attributes were not ranked high 
in terms of the six characteristics presented to practitioners.
4  Discussion
This study shows that DCEs can be used to elicit the pref-
erences of clinical practitioners in informing the design 
of a new medical device. This is the first published DCE 
we are aware of that has investigated the preferences of 
primary care practitioners in the UK for a new medical 
device. It is also the first DCE we are aware of to explore 
preferences for a novel PAD detection device for primary 
care. Practitioners generally had strong preferences for five 
of the six attributes that were used to describe the charac-
teristics of the PAD detection device.
4.1  Interpretation of Findings
Practitioners particularly favoured manual, as opposed 
to automated, integration of test result data onto patient 
records. The feedback obtained from the pre-pilot think-
aloud interviews supported this outcome. Feedback from one 
of the pre-pilot respondents was that automated integration 
could cause compatibility issues with the record-keeping 
system in the future. The compatibility issue flagged the 
requirement for an ongoing maintenance and service con-
tract to be available to keep the integration software up-
to-date with NHS systems (and other software updates). 
This issue was thought to be a barrier to using a new device 
where data integration was automated, and, while flagged as 
a particular problem, it also highlights a wider issue about 
compatibility with systems between localities, e.g. between 
countries. It is unclear whether the ability to integrate with 
standard information systems would be a barrier or facilita-
tor in different countries; however, it is clear that if integra-
tion was required, the solution would need to be tailored to 
each system.
A significantly higher value was placed on a device using 
disposable batteries as the power supply compared with all 
other alternatives. Again, feedback from the pre-pilot think-
aloud interviews supported this outcome. In two of the think-
aloud interviews, participants mentioned that devices such as 
this that may not be purchased for individual staff, but for group 
use, will not likely be kept charged. The issue that was brought 
to light in the think-aloud conversations was that when a device 
like this is targeted to be used in a home setting, there would 
be issues of access to a mains electricity socket in patients’ 
homes. Therefore, when a plug socket is available, it may hinder 
interaction with the patient and ease of movement around the 
patient, especially when the patient is in a lying position. The 
findings need to be considered in line with the context of the 
situation; for example, environmental concerns about dispos-
able items such as batteries (and the cost of their disposal) may 
reduce the uptake of a device if this was the sole option.
In terms of the cost of the device, contrary to what would 
have been expected, a significantly less-favourable attitude 
towards a higher priced device was not observed. This may 
reflect the lack of suitable devices currently available and 
participants’ willingness to pay more to have a more suit-
able device available. Within the pre-pilot think-aloud inter-
views, respondents were very conscious of the cost of the 
Table 4  Ranking of DCE 
attributes
DCE discrete-choice experiment
a Of the 116 individuals who fully completed the DCE survey, one of these individuals attached a rank to 
only one of the six attributes
Ranking Attribute ranking frequency (%)
Cost Display Portability Integration Training Power
1 49 (42.2) 25 (21.6) 23 (19.8) 11 (9.5) 6 (5.2) 2 (1.7)
2 24 (20.7) 22 (19) 34 (29.3) 22 (19) 8 (6.9) 5 (4.3)
3 17 (14.7) 18 (15.5) 22 (19) 27 (23.3) 15 (12.9) 16 (13.8)
4 9 (7.8) 23 (19.8) 18 (15.5) 28 (24.1) 18 (15.5) 19 (16.4)
5 13 (11.2) 12 (10.3) 10 (8.6) 16 (13.8) 36 (31) 28 (24.1)
6 3 (2.6) 15 (12.9) 8 (6.9) 11 (9.5) 32 (27.6) 46 (39.7)
Total (n)a 115 115 115 115 115 116
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device and that a realistic price, in comparison with similar 
devices, should be set. When the price levels for the device 
were set within the DCE, we deliberately set prices in small 
increments and took into account the maximum price range 
participants suggested in the think-aloud interviews. This was 
done in order to ensure the cost attribute was not the sole 
deciding factor that was considered when practitioners were 
considering the two hypothetical scenarios. The coefficient 
for the cost attribute was positive and significant. There are 
three possible explanations for this finding: (1) practitioners 
mainly considered the levels of the remaining five attributes, 
and, in the majority of the choice sets, the alternative that was 
chosen was coincidentally the more expensive option; (2) the 
sample size was too small in order to be able to distinguish 
between the different levels of the cost attribute; or (3) unlike 
the vast majority of DCE studies in health care settings to 
date that have been conducted in patient samples, the cost is 
not borne by the DCE participant directly, hence they may be 
relatively insensitive to impacts upon health system budgets 
as opposed to direct personal budgets. The conditional logit 
model did not converge when the cost attribute was estimated 
as a categorical variable as opposed to a continuous variable, 
potentially supporting the latter explanation.
4.2  Limitations of the Study
This study had some limitations. First, a main-effects-only 
design was used. This type of design assumes that all attrib-
utes are independent of each other, and were valued as such 
by study participants (i.e. all interactions between attributes 
were zero). Given the context of the current study, this may 
be reasonable since the six different medical device design 
characteristics can be treated as independent. In addition to 
this, we did not include an opt-out option in the choice tasks, 
therefore participants were asked to make a forced choice 
between the two scenarios presented, and did not have the 
ability to choose neither option, which might have indicated 
their preference for the device that they currently use. A 
future study can look into estimation of uptake rates for 
MPPG-based technology when compared with commonly 
used existing devices for ABPI measurements. Related to 
this, future studies can also assess the issue heterogene-
ity using more complex model specifications such as the 
mixed logit model. Second, this study used an online survey 
whereby the practitioners’ answers were collected electron-
ically. Although easier to administer the survey using an 
electronic format, an interviewer-based administration may 
have been more reliable in terms of ensuing participants 
truly understood the task being asked of them. Nevertheless, 
only three (3%) participants found the DCE questions dif-
ficult to answer. Added to this, the sample mainly consisted 
of GPs; however, it is not yet known whether nurses would 
have had different preferences to GPs. It is worth noting that 
in practice currently, the ABPI test is usually administered 
by a nurse rather than a GP. Finally, the results of this study 
may not be generalisable to the secondary care setting as the 
device is currently being developed specifically for users 
in the primary care setting. Additionally, the majority of 
respondents came from the North of England and it would 
be difficult to evaluate the representativeness of the findings 
to the wider UK context.
When developing the DCE, choices had to be made about 
how many attributes and levels could be included. In par-
ticular the device display attribute was the only one that 
included a pictorial set of levels. This might have resulted 
in study participants treating this attribute differently to the 
others. Some potentially relevant attributes, such as the type 
of measurement probe, were not considered because they 
were not identified as sufficiently important in preparatory 
work.
4.3  Lessons for Future Studies Using DCE to Inform 
the Design of New Medical Devices/Conclusion
This study has shown that a DCE can usefully be used to 
help understand the key attributes to users of a medical 
device. This in turn can help identify design characteristics 
of the device that would maximise the benefit, and hence 
uptake, to users. Typically, attributes and levels included 
in the DCE can be set to describe the current state (in this 
context, the currently used device in general practices, which 
is the ABPI). Levels within device characteristics/attributes 
can then be altered in order to explore relative preferences 
for changes to the current device, to the new device, to allow 
predictions of uptake of the new device [7]. In the current 
study, device characteristics and their associated levels 
described the configuration of the proposed new MPPG-
based device. The characteristics of the device are very dif-
ferent to ABPI in a number of ways. For example, there is 
usually no display available with the manual ABPI method 
(except in the case of auto ABPI devices), therefore this 
attribute is not a characteristic that is transferable to MPPG 
technology. Although we cannot estimate uptake rates for 
MPPG-based technology when compared with commonly 
used existing devices for ABPI measurements, we do know 
that display, as well as cost, were the top-ranking character-
istics for a new PAD detection device, by GPs. Given that 
ABPI does not provide a results display, this might have 
a strong influence on the uptake of MPPG technology for 
PAD detection.
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